Oslo University Hospital: Breast Neoplasms trials

The registry lists 10 Breast Neoplasms studies with Oslo University Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Increasing Access to Breast Cancer Screening Among ImmigrantsActive, not recruitingNCT04672265Not applicable
• Pre-operative Hypnosis to Prevent Side Effects After SurgeryCompletedNCT04300283Not applicable
• Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast CancerActive, not recruitingNCT03904173
• Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast CancerCompletedNCT03409198Phase 2
• Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast CancerCompletedNCT03164993Phase 2
• Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic SettingActive, not recruitingNCT02546232Phase 2
• Energy Balance and Breast Cancer Aspects-IIActive, not recruitingNCT02240836Not applicable
• Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant TreatmentTerminatedNCT02017496
• Cancer Patients' Knowledge About FatigueStatus unknownNCT00927433Not applicable
• Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone MarrowCompletedNCT00248703Phase 2